{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49v1.1","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10072","date":"2021-11-04T16:00:00.000Z","role":"Approver"},{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10072","date":"2022-07-12T15:26:40.959Z","role":"Publisher"}],"evidence":[{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:4dec89ae-707a-4e92-8c96-98d3fa2f2323_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:4dec89ae-707a-4e92-8c96-98d3fa2f2323","type":"Proband","allele":[{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342906"}},{"id":"cggv:d2f1fcb2-ef62-436d-8700-e133e2c4b9df","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.817A>G (p.Asn273Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA260592"}}],"sex":"UnknownEthnicity","variant":[{"id":"cggv:5c1376e3-d2fa-490c-bd51-f5529377b5c3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/22842231","type":"dc:BibliographicResource","dc:abstract":"Leber congenital amaurosis (LCA) is an autosomal recessive retinal dystrophy that manifests with genetic heterogeneity. We sequenced the exome of an individual with LCA and identified nonsense (c.507G>A, p.Trp169*) and missense (c.769G>A, p.Glu257Lys) mutations in NMNAT1, which encodes an enzyme in the nicotinamide adenine dinucleotide (NAD) biosynthesis pathway implicated in protection against axonal degeneration. We also found NMNAT1 mutations in ten other individuals with LCA, all of whom carry the p.Glu257Lys variant.","dc:creator":"Chiang PW","dc:date":"2012","dc:title":"Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis."}},{"id":"cggv:5e41c5e5-a36b-4f32-98f1-64fa78f23086_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d2f1fcb2-ef62-436d-8700-e133e2c4b9df"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"}],"rdfs:label":"Table 1 - 4"},{"id":"cggv:5c1376e3-d2fa-490c-bd51-f5529377b5c3","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5c1376e3-d2fa-490c-bd51-f5529377b5c3_variant_evidence_item"},{"id":"cggv:5c1376e3-d2fa-490c-bd51-f5529377b5c3_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:5e41c5e5-a36b-4f32-98f1-64fa78f23086","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5e41c5e5-a36b-4f32-98f1-64fa78f23086_variant_evidence_item"},{"id":"cggv:5e41c5e5-a36b-4f32-98f1-64fa78f23086_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:2a3d30b9-b24b-4fe8-af01-fe536157e419_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2a3d30b9-b24b-4fe8-af01-fe536157e419","type":"Proband","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"sex":"Male","variant":{"id":"cggv:fdb6c634-05b3-4a84-9629-8ea491dc744f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/22842230","type":"dc:BibliographicResource","dc:abstract":"Leber congenital amaurosis (LCA) is a blinding retinal disease that presents within the first year after birth. Using exome sequencing, we identified mutations in the nicotinamide adenine dinucleotide (NAD) synthase gene NMNAT1 encoding nicotinamide mononucleotide adenylyltransferase 1 in eight families with LCA, including the family in which LCA was originally linked to the LCA9 locus. Notably, all individuals with NMNAT1 mutations also have macular colobomas, which are severe degenerative entities of the central retina (fovea) devoid of tissue and photoreceptors. Functional assays of the proteins encoded by the mutant alleles identified in our study showed that the mutations reduce the enzymatic activity of NMNAT1 in NAD biosynthesis and affect protein folding. Of note, recent characterization of the slow Wallerian degeneration (Wld(s)) mouse model, in which prolonged axonal survival after injury is observed, identified NMNAT1 as a neuroprotective protein when ectopically expressed. Our findings identify a new disease mechanism underlying LCA and provide the first link between endogenous NMNAT1 dysfunction and a human nervous system disorder.","dc:creator":"Koenekoop RK","dc:date":"2012","dc:title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration."}},"rdfs:label":"Table 1 - 624"},{"id":"cggv:fdb6c634-05b3-4a84-9629-8ea491dc744f","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:fdb6c634-05b3-4a84-9629-8ea491dc744f_variant_evidence_item"},{"id":"cggv:fdb6c634-05b3-4a84-9629-8ea491dc744f_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:5e17b04f-4b88-4ec1-8602-f2e0d1786cec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:5e17b04f-4b88-4ec1-8602-f2e0d1786cec","type":"Proband","allele":[{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.507G>A (p.Trp169Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA579271"}},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"UnknownEthnicity","variant":[{"id":"cggv:e19e6cd1-6f73-4379-843b-f5055baaf119_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"},{"id":"cggv:84834c2e-a9b4-403d-be49-b1189581bd3d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"}],"rdfs:label":"Table 1 - 3"},{"id":"cggv:84834c2e-a9b4-403d-be49-b1189581bd3d","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:84834c2e-a9b4-403d-be49-b1189581bd3d_variant_evidence_item"},{"id":"cggv:84834c2e-a9b4-403d-be49-b1189581bd3d_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:e19e6cd1-6f73-4379-843b-f5055baaf119","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:e19e6cd1-6f73-4379-843b-f5055baaf119_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0dfd998e-d219-4b77-ae8d-f6a8ca1a2cfc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0dfd998e-d219-4b77-ae8d-f6a8ca1a2cfc","type":"Proband","allele":[{"id":"cggv:e611fbdf-9166-46f9-a5e4-0a041255e791","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.245T>C (p.Val82Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1062688"}},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"Male","variant":[{"id":"cggv:e3816094-9bce-4d80-9107-9f254758281d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e611fbdf-9166-46f9-a5e4-0a041255e791"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/32150116","type":"dc:BibliographicResource","dc:abstract":"To describe in detail the phenotype of two siblings with biallelic NMNAT1 mutations.","dc:creator":"Bedoukian EC","dc:date":"2020","dc:title":"NMNAT1-ASSOCIATED CONE-ROD DYSTROPHY: EVIDENCE FOR A SPECTRUM OF FOVEAL MALDEVELOPMENT."}},{"id":"cggv:f9077d55-4651-4c92-9b8c-d6879f8c17bf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/32150116"}],"rdfs:label":"P1"},{"id":"cggv:f9077d55-4651-4c92-9b8c-d6879f8c17bf","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:f9077d55-4651-4c92-9b8c-d6879f8c17bf_variant_evidence_item"},{"id":"cggv:f9077d55-4651-4c92-9b8c-d6879f8c17bf_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:e3816094-9bce-4d80-9107-9f254758281d","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:e3816094-9bce-4d80-9107-9f254758281d_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0bf75811-8ece-473a-b897-ffd004f4fc02_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0bf75811-8ece-473a-b897-ffd004f4fc02","type":"Proband","allele":[{"id":"cggv:a8a49ee4-0320-47e4-bbcd-5936e3cd4db2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.293T>G (p.Val98Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/866255"}},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"UnknownEthnicity","variant":[{"id":"cggv:56c8c8da-d2b6-497c-abd2-55ccf315d266_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a8a49ee4-0320-47e4-bbcd-5936e3cd4db2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"},{"id":"cggv:8079b50d-f0d8-4f5c-9d6a-f978a40b6671_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"}],"rdfs:label":"Table 1 - 5"},{"id":"cggv:56c8c8da-d2b6-497c-abd2-55ccf315d266","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:56c8c8da-d2b6-497c-abd2-55ccf315d266_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:8079b50d-f0d8-4f5c-9d6a-f978a40b6671","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:8079b50d-f0d8-4f5c-9d6a-f978a40b6671_variant_evidence_item"},{"id":"cggv:8079b50d-f0d8-4f5c-9d6a-f978a40b6671_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:3846ea2e-34c5-40d1-9c2d-cd8ee1f6a0c5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:3846ea2e-34c5-40d1-9c2d-cd8ee1f6a0c5","type":"Proband","allele":[{"id":"cggv:0d8ea236-f7bc-4de4-b614-b06aa3366124","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.619C>T (p.Arg207Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA260590"}},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"Male","variant":[{"id":"cggv:d1d0d3ba-0cf7-4254-bbc1-aae07ae02d36_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0d8ea236-f7bc-4de4-b614-b06aa3366124"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"},{"id":"cggv:c475b0a5-a5e0-462c-9e1f-cdbc5a077d6c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"}],"rdfs:label":"Table 1 - 512"},{"id":"cggv:c475b0a5-a5e0-462c-9e1f-cdbc5a077d6c","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c475b0a5-a5e0-462c-9e1f-cdbc5a077d6c_variant_evidence_item"},{"id":"cggv:c475b0a5-a5e0-462c-9e1f-cdbc5a077d6c_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:d1d0d3ba-0cf7-4254-bbc1-aae07ae02d36","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d1d0d3ba-0cf7-4254-bbc1-aae07ae02d36_variant_evidence_item"},{"id":"cggv:d1d0d3ba-0cf7-4254-bbc1-aae07ae02d36_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:695daec7-2631-44bd-a403-076cb94c8801_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:695daec7-2631-44bd-a403-076cb94c8801","type":"Proband","allele":[{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},{"id":"cggv:d2f1fcb2-ef62-436d-8700-e133e2c4b9df"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"sex":"Female","variant":[{"id":"cggv:9b0d09c6-7aa2-4385-96a6-4ec36ad47cfe_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"},{"id":"cggv:c435e83d-cd35-4079-87b6-784c770b609f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d2f1fcb2-ef62-436d-8700-e133e2c4b9df"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"}],"rdfs:label":"Table 1 - 208"},{"id":"cggv:c435e83d-cd35-4079-87b6-784c770b609f","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c435e83d-cd35-4079-87b6-784c770b609f_variant_evidence_item"},{"id":"cggv:c435e83d-cd35-4079-87b6-784c770b609f_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:9b0d09c6-7aa2-4385-96a6-4ec36ad47cfe","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:9b0d09c6-7aa2-4385-96a6-4ec36ad47cfe_variant_evidence_item"},{"id":"cggv:9b0d09c6-7aa2-4385-96a6-4ec36ad47cfe_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:072d958a-35b5-4597-9712-031b44689328_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:072d958a-35b5-4597-9712-031b44689328","type":"Proband","allele":[{"id":"cggv:9aadc0cb-9579-4b1e-8d3b-863f2fc98f6e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.199G>T (p.Val67Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/871049"}},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"UnknownEthnicity","variant":[{"id":"cggv:31d9b771-a3ea-4013-98d5-48c8799ef527_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9aadc0cb-9579-4b1e-8d3b-863f2fc98f6e"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"},{"id":"cggv:a7f06fc2-f17b-4f73-8353-32758160f760_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"}],"rdfs:label":"Table 1 - 3294"},{"id":"cggv:31d9b771-a3ea-4013-98d5-48c8799ef527","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:31d9b771-a3ea-4013-98d5-48c8799ef527_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:a7f06fc2-f17b-4f73-8353-32758160f760","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:a7f06fc2-f17b-4f73-8353-32758160f760_variant_evidence_item"},{"id":"cggv:a7f06fc2-f17b-4f73-8353-32758160f760_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:90ed5546-f035-44c9-973f-8fd76be94756_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:90ed5546-f035-44c9-973f-8fd76be94756","type":"Proband","allele":[{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},{"id":"cggv:b815caa2-5532-4b35-bf48-b7bac02870bf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.205A>G (p.Met69Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/972092"}}],"sex":"Female","variant":[{"id":"cggv:07178f45-0a92-45b1-8c53-4d292a18df40_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/22842227","type":"dc:BibliographicResource","dc:abstract":"Leber congenital amaurosis (LCA) is an infantile-onset form of inherited retinal degeneration characterized by severe vision loss(1,2). Two-thirds of LCA cases are caused by mutations in 17 known disease-associated genes(3) (Retinal Information Network (RetNet)). Using exome sequencing we identified a homozygous missense mutation (c.25G>A, p.Val9Met) in NMNAT1 that is likely to be disease causing in two siblings of a consanguineous Pakistani kindred affected by LCA. This mutation segregated with disease in the kindred, including in three other children with LCA. NMNAT1 resides in the previously identified LCA9 locus and encodes the nuclear isoform of nicotinamide mononucleotide adenylyltransferase, a rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD(+)) biosynthesis(4,5). Functional studies showed that the p.Val9Met alteration decreased NMNAT1 enzyme activity. Sequencing NMNAT1 in 284 unrelated families with LCA identified 14 rare mutations in 13 additional affected individuals. These results are the first to link an NMNAT isoform to disease in humans and indicate that NMNAT1 mutations cause LCA.","dc:creator":"Falk MJ","dc:date":"2012","dc:title":"NMNAT1 mutations cause Leber congenital amaurosis."}},{"id":"cggv:9e9bd47f-320d-4cec-8d2c-d5e456c6e1ac_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b815caa2-5532-4b35-bf48-b7bac02870bf"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842227"}],"rdfs:label":"Family 053 - II-1"},{"id":"cggv:07178f45-0a92-45b1-8c53-4d292a18df40","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:07178f45-0a92-45b1-8c53-4d292a18df40_variant_evidence_item"},{"id":"cggv:07178f45-0a92-45b1-8c53-4d292a18df40_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:9e9bd47f-320d-4cec-8d2c-d5e456c6e1ac","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:9e9bd47f-320d-4cec-8d2c-d5e456c6e1ac_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_seg_el","type":"EvidenceLine","specifiedBy":"GeneValiditySegregationEvidencCriteria","strengthScore":1.5},{"id":"cggv:04429dca-bca5-4496-a318-21a003548dfc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:04429dca-bca5-4496-a318-21a003548dfc","type":"Proband","allele":[{"id":"cggv:15911561-ce42-4574-a6e2-1fcb06717433","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.709C>T (p.Arg237Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/845745"}},{"id":"cggv:185e608e-c62a-4345-a1be-80e4798a3aa8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.196C>T (p.Arg66Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/982555"}}],"sex":"Female","variant":[{"id":"cggv:584e7e25-b7c5-4ecd-b4cb-a95b8f87658a_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:15911561-ce42-4574-a6e2-1fcb06717433"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842227"},{"id":"cggv:d5e09cec-8a8f-4043-bf34-c82eef48533b_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:185e608e-c62a-4345-a1be-80e4798a3aa8"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842227"}],"rdfs:label":"Family 007 - II-2"},{"id":"cggv:584e7e25-b7c5-4ecd-b4cb-a95b8f87658a","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:584e7e25-b7c5-4ecd-b4cb-a95b8f87658a_variant_evidence_item"},{"id":"cggv:584e7e25-b7c5-4ecd-b4cb-a95b8f87658a_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22832227) The NAD+ biosynthetic activities of WT and mutant purified recombinant NMNAT1 proteins were measures. Compared to WT, V9M and R237C had lower enzyme activities, whereas W169A and R66W had no enzyme activities"}],"strengthScore":0.5},{"id":"cggv:d5e09cec-8a8f-4043-bf34-c82eef48533b","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d5e09cec-8a8f-4043-bf34-c82eef48533b_variant_evidence_item"},{"id":"cggv:d5e09cec-8a8f-4043-bf34-c82eef48533b_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22832227) The NAD+ biosynthetic activities of WT and mutant purified recombinant NMNAT1 proteins were measures. Compared to WT, V9M and R237C had lower enzyme activities, whereas W169A and R66W had no enzyme activities"}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:52b53632-3eee-49ab-b79b-831154ea562d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:52b53632-3eee-49ab-b79b-831154ea562d","type":"Proband","allele":[{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"},{"id":"cggv:43b57577-a7a8-47c1-bf4d-5405189cd05f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.710G>T (p.Arg237Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA260596"}}],"sex":"Female","variant":[{"id":"cggv:fe4cba14-f025-4d02-9e20-99987aeac965_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"},{"id":"cggv:cf6625f1-1c9f-43ec-afae-cedbf9417dcf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:43b57577-a7a8-47c1-bf4d-5405189cd05f"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"}],"rdfs:label":"Table 1 - 3174"},{"id":"cggv:fe4cba14-f025-4d02-9e20-99987aeac965","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:fe4cba14-f025-4d02-9e20-99987aeac965_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:cf6625f1-1c9f-43ec-afae-cedbf9417dcf","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:cf6625f1-1c9f-43ec-afae-cedbf9417dcf_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:6856f8b1-f9a9-4e76-bdae-d3af32faa5fb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:6856f8b1-f9a9-4e76-bdae-d3af32faa5fb","type":"Proband","allele":[{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"UnknownEthnicity","variant":[{"id":"cggv:411a31d9-764c-4a20-9b67-eadedfbf2286_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"},{"id":"cggv:46b0eb93-5e17-4f87-9356-a5a4039cc570_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"}],"rdfs:label":"Table 1 - 1 "},{"id":"cggv:46b0eb93-5e17-4f87-9356-a5a4039cc570","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:46b0eb93-5e17-4f87-9356-a5a4039cc570_variant_evidence_item"},{"id":"cggv:46b0eb93-5e17-4f87-9356-a5a4039cc570_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:411a31d9-764c-4a20-9b67-eadedfbf2286","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:411a31d9-764c-4a20-9b67-eadedfbf2286_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:7766f00d-d7f0-46b6-84c7-d23c5160ebb8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:7766f00d-d7f0-46b6-84c7-d23c5160ebb8","type":"Proband","allele":[{"id":"cggv:944b637a-b56f-460b-9f46-559c7bc0d8f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022787.4(NMNAT1):c.451G>T (p.Val151Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA260594"}},{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"}],"sex":"Female","variant":[{"id":"cggv:ceae255d-8ea4-426d-89b1-cd7dd7363dca_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:944b637a-b56f-460b-9f46-559c7bc0d8f2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"},{"id":"cggv:719f851d-899f-4ce8-8ccd-7e29c630644b_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230"}],"rdfs:label":"Table 1 - 1269"},{"id":"cggv:719f851d-899f-4ce8-8ccd-7e29c630644b","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:719f851d-899f-4ce8-8ccd-7e29c630644b_variant_evidence_item"},{"id":"cggv:719f851d-899f-4ce8-8ccd-7e29c630644b_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5},{"id":"cggv:ceae255d-8ea4-426d-89b1-cd7dd7363dca","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ceae255d-8ea4-426d-89b1-cd7dd7363dca_variant_evidence_item"},{"id":"cggv:ceae255d-8ea4-426d-89b1-cd7dd7363dca_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:9ec1f9a2-9c8a-41c3-a683-0e6d75d250b2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:9ec1f9a2-9c8a-41c3-a683-0e6d75d250b2","type":"Proband","allele":[{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"}],"sex":"UnknownEthnicity","variant":[{"id":"cggv:6f4832e7-affc-4380-a593-503ce5a04e31_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ab4621eb-d348-4f2b-9de2-35a1c1a22d45"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"},{"id":"cggv:0c2072d8-db5d-4bc3-8e57-daaec78ce565_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:185bb084-7113-4f67-adf6-aec1ed0faebb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842231"}],"rdfs:label":"Table 1 - 2"},{"id":"cggv:0c2072d8-db5d-4bc3-8e57-daaec78ce565","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:0c2072d8-db5d-4bc3-8e57-daaec78ce565_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:6f4832e7-affc-4380-a593-503ce5a04e31","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:6f4832e7-affc-4380-a593-503ce5a04e31_variant_evidence_item"},{"id":"cggv:6f4832e7-affc-4380-a593-503ce5a04e31_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"(PMID: 22842230) HeLa cells were transfected with constructed encoding wild-type or mutant (V151F, R207W, E257K, or N273D).  Compared with WT, all mutants had lower enzymatic activities. "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:908fc574-20da-4485-951c-1f4c65c6aaa8_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:8a3e0654-8346-44db-82e9-44d06622502c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c186dc13-1e19-4402-a4da-8e1b3f30cc0b","type":"FunctionalAlteration","dc:description":"The p.Trp169Ala mutant had no NMNAT1 enzyme activity (n = 6; P = 0.0014), as was previously reported32. The p.Val9Met mutant had significantly lower enzyme activity (37% of wild-type NMNAT1 activity) (n = 7; P = 0.0015). The p.Arg237Cys mutant had 81% of wild-type NMNAT1 activity (n = 6; P = 0.034). The p.Arg66Trp mutant had no NMNAT1 enzyme activity (n = 6; P = 0.0014). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842227","rdfs:label":"NMNAT1 enzyme activity"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"cggv:f549b25b-42a5-44bc-a2be-af3b765dbb52","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:2d0879f6-844e-4930-908b-9ff655d73e11","type":"FunctionalAlteration","dc:description":"Compared with wild-type (WT) NMNAT1, the p.Val151Phe, p.Arg207Trp, p.Glu257Lys\nand p.Asn273Asp variants had lower enzymatic activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230","rdfs:label":"In-vitro studies on enzyme activities"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"cggv:e29765d8-3aeb-45c3-a2d4-151ab43adcf1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"cggv:0d0f9236-5c5a-4dfe-af13-ae74a744bbfc","type":"FunctionalAlteration","dc:description":"NAD is present at significantly lower levels in the affected proband compared with his carrier mother (****P < 0.0001)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22842230","rdfs:label":"Total NAD levels in fresh RBCs from affected"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":4803,"specifiedBy":"GeneValidityCriteria9","strengthScore":14,"subject":{"id":"cggv:2f8f558a-6faf-46ab-a178-cd98d6c24f14","type":"GeneValidityProposition","disease":"obo:MONDO_0800101","gene":"hgnc:17877","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","dc:description":"NMNAT1 was first reported in relation to NMNAT1-related retinopathy in 2012 in a patient described as having autosomal recessive Leber congenital amaurosis (PMID: 22842230, 22842231, 22842227). Leber congenital amaurosis (LCA) is a severe form of inherited photoreceptor-neuron degeneration resulting in congenital blindness. \nTo take into account the range of phenotypes and genetic heterogeneity in retinal disorders, the ClinGen Retina GCEP has labeled the disease entity associated with biallelic variants in NMNAT1 as \"NMNAT1-related retinopathy\".\nAt least 14 variants (missense and nonsense) that have been reported in 15 probands in publications (PMID: 22842230, 22842231, 22842227, 32150116). Variants in NMNAT1 was found to be segregated in at least one large family (PMID: 22842230).More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease association is also supported by in-vitro studies (e.g. animal models, expression studies, in vitro functional assays, etc.) (PMIDs: 22842230, 22842227). When measuring NAD levels in red blood cells, affected individuals with homozygous NMNAT1 variant had significantly lower levels of NAD compared to unaffected carrier (PMID: 22842230). Other in-vitro studies showed that, when cells are transfected with constructs encoding wild-type or mutant NMNAT1, those with NMNAT1 variants had lower enzymatic activities, compared to wildtype (PMID: 22842230, 22842227). Of note, one study demonstrated that patients with two homozygous variants in NMNAT in a large consanguineous family presented with global developmental delay, hypotonia with joint hypermobility and autism, in addition to LCA (PMID: 22842227). A limited number of patients have been recorded as having spondyloepiphyseal dysplasia syndrome (SHILCA), including sensorineural hearing loss, intellectual disability in addition to LCA, however additional studies are needed to definitively describe this disease association (PMID: 33668384, 32533184).\nIn summary, NMNAT1 is definitively associated with autosomal recessive NMNAT1-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.\n","dc:isVersionOf":{"id":"cggv:a6733bc3-489d-413d-9dbe-1bca25f48d49"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}